These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 12112968)

  • 1. The mifepristone-misoprostol regimen for early medical abortion.
    Ellertson C; Waldman SN
    Curr Womens Health Rep; 2001 Dec; 1(3):184-90. PubMed ID: 12112968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-administration of misoprostol for termination of pregnancy: safety and efficacy.
    Kiran U; Amin P; Penketh RJ
    J Obstet Gynaecol; 2004 Feb; 24(2):155-6. PubMed ID: 14766452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early medical abortion: a new regimen up to 49 days' gestation.
    Ashima T; Vinita A; Shalini R
    Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):137-9. PubMed ID: 15760315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium sordellii toxic shock syndrome after medical abortion with mifepristone and intravaginal misoprostol--United States and Canada, 2001-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Jul; 54(29):724. PubMed ID: 16049422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
    Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
    Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-administration of vaginal misoprostol after mifepristone for termination of pregnancy: patient acceptability.
    Kiran U; Amin P; Penketh RJ
    J Obstet Gynaecol; 2006 Oct; 26(7):679-81. PubMed ID: 17071439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical and surgical options for induced abortion in first trimester.
    Hamoda H; Templeton A
    Best Pract Res Clin Obstet Gynaecol; 2010 Aug; 24(4):503-16. PubMed ID: 20418168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Issues in second trimester induced abortion (medical/surgical methods).
    Lee VC; Ng EH; Ho PC
    Best Pract Res Clin Obstet Gynaecol; 2010 Aug; 24(4):517-27. PubMed ID: 20347397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical options for early pregnancy termination.
    Gold M; Luks D; Anderson MR
    Am Fam Physician; 1997 Aug; 56(2):533-8. PubMed ID: 9262533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mifepristone (RU 486) in the United States. What does the future hold?
    Rosenfield A
    N Engl J Med; 1993 May; 328(21):1560-1. PubMed ID: 8479494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan.
    Louie KS; Tsereteli T; Chong E; Aliyeva F; Rzayeva G; Winikoff B
    Eur J Contracept Reprod Health Care; 2014 Dec; 19(6):457-64. PubMed ID: 25047120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study on the use of letrozole with either misoprostol or mifepristone for termination of pregnancy up to 63 days.
    Lee VC; Tang OS; Ng EH; Yeung WS; Ho PC
    Contraception; 2011 Jan; 83(1):62-7. PubMed ID: 21134505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, Safety, and Acceptability of Low-Dose Mifepristone and Self-Administered Misoprostol for Ultra-Early Medical Abortion: A Randomized Controlled Trial.
    Li CL; Song LP; Tang SY; Zhou LJGY; He H; Mo XT; Liao YM
    Reprod Sci; 2017 May; 24(5):731-737. PubMed ID: 27678099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
    Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical abortion: overview and management.
    Trupin SR; Moreno C
    Medscape Womens Health; 2001 Dec; 6(6):4. PubMed ID: 11965218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on uterine contractility following mifepristone and various routes of misoprostol.
    Gemzell-Danielsson K; Bygdeman M; Aronsson A
    Contraception; 2006 Jul; 74(1):31-5. PubMed ID: 16781257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
    Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
    Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.